Expression of calbindin D28K in the dopaminergic mesotelencephalic system in embryonic and fetal human brain.
A subset of tyrosine-hydroxylase (TH) neurons of the substantia nigra (A9) containing calbindin D28K (CaBP) appeared to be less vulnerable to cell death induced by Parkinson's disease than the subset containing dopamine (DA) alone. Because grafting procedures of fetal human neurons are increasingly used in the therapy of Parkinson's disease, it is important to study the development of DA neurons coexpressing CaBP. In humans, the genesis of TH immunoreactivity of A9, of the ventral tegmental area (A10), and of the retrorubral area (A8) occurred during a 2-week period from the 4. 5th gestational week (g.w.) in the ventricular zone of the floor plate and the contiguous basal plate of the mesencephalon and diencephalon, i.e., the prosomeres p1-p3. Double-immunolabeled TH-CaBP neurons were detected from 5.5 g.w. on, in the first wave of DA neuron's migration, and were observed in their final residence in the dorsal A9 by 10.5 g.w. Calretinin immunoreactivity was expressed in TH-immunoreactive (IR) neurons from 10.5 g.w. on. Ascending TH-CaBP-IR axons were observed toward the telencephalon from 6-7 g.w. , reaching the anlage of the nucleus accumbens and amygdaloid complex at 10.5 g.w., but were not detected in the ganglionic eminence at this latter stage. Dopaminergic patches were detected at 13 g.w. in the anlage of the putamen, but no TH-CaBP-IR fibers were observed in the matrix at this stage. In conclusion, even if CaBP immunoreactivity was detected in TH-IR cell bodies during the embryonic period, the TH-CaBP-IR axonal terminal was observed earlier in some limbic-related areas than in the matrix compartment of the basal ganglia in humans.
Verney
C
C
INSERM U.106, Hôpital Salpêtrière, 75651 Paris, France. cverney@infobiogen.fr
Zecevic
N
N
Ezan
P
P
D001369:Axons / Q000378:metabolism / Q000648:ultrastructure; D016380:Brain Tissue Transplantation / Q000379:methods; D064092:Calbindin 1; D064026:Calbindins; D016923:Cell Death / Q000502:physiology; D002465:Cell Movement / Q000502:physiology; D004298:Dopamine / Q000378:metabolism*; D016332:Fetal Tissue Transplantation / Q000379:methods; D005333:Fetus; D006801:Humans; D009434:Neural Pathways / Q000166:cytology / Q000196:embryology* / Q000378:metabolism; D009474:Neurons / Q000166:cytology / Q000378:metabolism* / Q000637:transplantation; D010300:Parkinson Disease / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D010487:Periaqueductal Gray / Q000166:cytology / Q000196:embryology / Q000378:metabolism; D064030:S100 Calcium Binding Protein G / Q000378:metabolism*; D013378:Substantia Nigra / Q000166:cytology / Q000196:embryology* / Q000378:metabolism; D013687:Telencephalon / Q000166:cytology / Q000196:embryology* / Q000378:metabolism; D017557:Ventral Tegmental Area / Q000166:cytology / Q000196:embryology* / Q000378:metabolism
C576498:CALB1 protein, human; D064092:Calbindin 1; D064026:Calbindins; D064030:S100 Calcium Binding Protein G; D004298:Dopamine